Spatial heterogeneity of radiolabeled choline positron emission tomography in tumors of patients with non-small cell lung cancer: first-in-patient evaluation of [18F]fluoromethyl-(1,2-2H4)-choline. (2020)
Attributed to:
Development of Metabolism Radiotracers to Probe Disease Pathology in Human Subjects with Cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.7150/thno.47298
PubMed Identifier: 32754271
Publication URI: http://europepmc.org/abstract/MED/32754271
Type: Journal Article/Review
Volume: 10
Parent Publication: Theranostics
Issue: 19
ISSN: 1838-7640